Clinical Trials Browser

Phase NA × Hypersensitivity × Other neoplasm × Clear all

NCT01837693 2025-06-26

NTCC2

Phase NA Completed

41,127 enrolled

GynecologicOther neoplasm

Uterine Cervical Neoplasms, Hypersensitivity, Neoplasms, Precancerous Conditions